Absolute Markets Insights has presented a statistical data to its extensive repository titled Genomic Medicine market. The study comprises different segments and sub-segments such as type, size, applications, and end-users. One of the many distinctive features of the report is it provides an analytical study of the global Genomic Medicine market based on various growth influencing factors. Primary and secondary research techniques have also been used by analysts of the report to study the market. Moreover, the report offers the entire demand-supply chain of a Genomic Medicine market to comprehend the demanding structure of the Genomic Medicine sector. In this effective and informative report, top-notch industries have been enlisted to provide a comprehensive analysis of successful strategies of various companies.

In June, 2021, Pacific Biosciences of California, Inc. who is one of the leading provider of high-quality, long-read sequencing platforms and Rady Children’s Institute for Genomic Medicine (RCIGM) announced that they are collaborating on a study which aims to identify potential disease-causing genetic variants and increase the solve rates of rare diseases. The study is focused on long-read whole genome sequencing of rare disease cases for which previous short-read whole genome and exome sequencing yielded no answers. The study, which is currently underway, was able to detect variants that were not identified by short-read sequencing (SRS); of these, an average of 37 was missense mutations in known disease genes.

Please click the link below to get a full report: https://www.industryglobalnews24.com/global-genomic-medicine-market-is-expected-to-grow-at-cagr-212-by-2029

It was estimated that as many as 25 million Americans, approximately 1 in 13 people are affected by a rare, and often undiagnosed condition. In rare disease studies, conventional techniques for whole-genome and whole-exome analysis based on SRS typically led to identification of a causal variant in less than 50% of cases. Utilizing PacBio’s Single Molecule, Real-Time (SMRT) Sequencing technology to generate highly accurate long-reads, known as HiFi reads, clinical researchers have demonstrated that they can detect disease-causing structural and small variants missed by short-read sequencing platforms.

 Key Players Operating in Global Genomic Medicine Market: Abomics Ltd, Cerecor, Inc. (Aevi Genomic Medicine, Inc.), Congenica Ltd, DEEP GENOMICS, Editas Medicine, EUROESPES, Genome Medical, Inc., Helix OpCo LLC, Parexel International Corporation, Sangamo Therapeutics, and uniQure N.V

Global Genomic Medicine Market: Key Segmentation

By Component

  • Gene Medicine
  • Platforms & Services

By Application

  • Oncology
  • Cardiology
  • Pediatrics
  • Endocrinology
  • Respiratory Medicine
  • Rare Genetic Disorders
  • Infectious Diseases
  • Diabetes
  • Others

By End Users

  • Hospitals & Clinics
  • Academic Institutes & Research Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Contact Us:

Company: Absolute Markets Insights

Email id: sales@absolutemarketsinsights.com

Phone: +91-740-024-2424

Contact Name: Shreyas Tanna

Website: https://www.absolutemarketsinsights.com/